Lipoprotein(a) and ASCVD Risk

Dr. Marlys Koschinsky describes Lipoprotein(a) and the increased risk for atherosclerotic cardiovascular disease (ASCVD). Join Dr. Koschinsky as she discusses measurement practices, the genetic link to Lipoprotein(a), and future treatment…

Read More

Non-Statin Therapies for Lipid Management

Susan Halli-Demeter, RN, DNP, CLS reviews the benefits of non-statin, LDL-C-lowering therapies for patients with very high-risk atherosclerotic cardiovascular disease (ASCVD) and severe hypercholesterolemia.

Read More

2021 Pharmacology Sessions

Clinical management of chronic cardiovascular disease is a key component of the work of advanced practice nurses and RNs in the cardiology and primary care settings. This annual pharmacology CE…

Read More